Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood.
10.3346/jkms.1999.14.5.520
- Author:
Sang Hee CHO
1
;
Ik Joo CHUNG
;
Je Jung LEE
;
Moo Lim PARK
;
Hyeoung Joon KIM
Author Information
1. Department of Internal Medicine, Chonnam National University Medical School, Kwangju, Korea.
- Publication Type:Original Article ; Comparative Study ; Research Support, Non-U.S. Gov't
- Keywords:
Antigens, CD34;
Stem cells;
Granulocyte-macrophage colony-stimulating factor;
Erythroid progenitor cells
- MeSH:
Adult;
Antigens, CD34/immunology*;
Bone Marrow/immunology*;
Colony-Forming Units Assay;
Comparative Study;
Fetal Blood/immunology*;
Flow Cytometry;
Granulocyte Colony-Stimulating Factor/pharmacology;
HLA-DR Antigens/immunology;
Hematopoietic Stem Cells/immunology*;
Human;
Leukocytes, Mononuclear/immunology;
Lymphocyte Subsets/immunology;
Male;
Phenotype;
Reference Values
- From:Journal of Korean Medical Science
1999;14(5):520-525
- CountryRepublic of Korea
- Language:English
-
Abstract:
To compare the clonogenicity and distribution of CD34+ subsets in bone marrow (BM), granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood (PB) and cord blood (CB), we analyzed in vitro colony formation and CD34+ cells co-expressing differentiation molecules (CD38, HLA-DR), myeloid associated molecules (CD13, CD33), a T-cell associated molecule (CD3), and a B-cell associated molecule (CD19) from mononuclear cells (MNCs) in the three compartments. The proportions of CD34+CD38- cells (BM: 4.4+/-2.8%, PB: 5.3+/-2.1%, CB: 5.9+/-3.9%) and CD34+HLA-DR cells (BM: 4.7+/-3.4%, PB: 5.5+/-2.3%, CB: 6.1+/-3.7%) did not differ significantly among the compartments. In contrast, a significantly higher proportion of CD34 cells of PB and CB co-expressed CD13 (75.0+/-11.4%, 77.7+/-17.3%) and CD33 (67.1 +/-5.7%, 56.8+/-10.3%) compared with those of BM (43.0+/-6.3%, 27.6+/-5.1%) and a significantly higher number of granulocyte-macrophage colony-forming units (CFU-GM) and erythroid burst-forming units (BFU-E) were detected in MNCs derived from PB and CB compared with those from BM (p<0.01). The proportion of CD34+CD19+ cells was higher in BM (34.9+/-11.9%) than those in PB (5.6+/-3.0%) and CB (4.7=2.1%) (p<0.05). The proportion of CD34+CD3+ was comparable in all three compartments. In conclusion, our findings show that MNCs of mobilized PB and CB display similar phenotypic profiles of CD34+ subsets and clonogenicity, different from those of BM.
